Novanta Inc. (NASDAQ:NOVT – Get Free Report) CFO Robert Buckley sold 1,830 shares of the business’s stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $161.09, for a total value of $294,794.70. Following the sale, the chief financial officer now directly owns 120,419 shares of the company’s stock, valued at $19,398,296.71. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Novanta Stock Performance
NOVT stock opened at $160.29 on Friday. The firm has a market cap of $5.75 billion, a PE ratio of 83.05 and a beta of 1.31. The company has a quick ratio of 1.77, a current ratio of 2.83 and a debt-to-equity ratio of 0.75. The business has a 50 day moving average of $162.22 and a 200-day moving average of $163.49. Novanta Inc. has a 12-month low of $111.20 and a 12-month high of $185.80.
Novanta (NASDAQ:NOVT – Get Free Report) last released its earnings results on Tuesday, May 7th. The technology company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.17. The company had revenue of $230.92 million during the quarter, compared to analyst estimates of $227.85 million. Novanta had a return on equity of 16.58% and a net margin of 7.76%. Novanta’s quarterly revenue was up 5.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.74 earnings per share. As a group, sell-side analysts expect that Novanta Inc. will post 3.26 earnings per share for the current year.
Hedge Funds Weigh In On Novanta
Novanta Company Profile
Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.
Featured Articles
- Five stocks we like better than Novanta
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- The 3 Best Fintech Stocks to Buy Now
- AbbVie Stock: A Perfect Dip for Investors to Buy
- 3 Best Fintech Stocks for a Portfolio Boost
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.